Usability of mHealth in Patient with Type 1 and Type 2 Diabetes Mellitus: A Review
Abstract
Diabetes mellitus (DM) is a group of metabolic illnesses identified by elevated blood glucose levels. The glycated hemoglobin (HbA1C) test is used to evaluate a person’s control of their blood glucose levels. According to a recent study, mHealth interventions may be particularly helpful for assisting patients with diabetes mellitus to self-monitor their status on their HbA1c level. Therefore, this systematic review aims to provide an overview of how mHealth affects individuals with diabetes mellitus, concentrating on HbA1c evaluation. A systematic review was conducted by reviewing the PubMed, Google Scholar, and Mendeley databases for randomized control trials published between February 2017 and September 2023. The studies of mHealth on the result of HbA1c were then examined. A drop in HbA1c was seen in all intervention groups. The overall average reduction in HbA1c across all intervention groups was - 0.79%, while the reduction in control groups was - 0.42%. The influence of mHealth could significantly reduce HbA1c levels. Studies show that HbA1c decreased more in patients who underwent a 3 to 6-month intervention. This study discovered 12 papers that discuss health for people with diabetes mellitus type 1 and 2. This study found that mHealth interventions significantly lower HbA1c in DM patients. For further research, bigger sample sizes and data on self-care results are needed. The views and perspectives of patients regarding the physical characteristics and design aspects of different interventions—mobile applications, texts, and phone calls—need to be further investigated.
Keywords
Full Text:
PDFReferences
Doupis J, Festas G, Tsilivigos C, Efthymiou V, Kokkinos A. Smartphone-Based Technology in Diabetes Management. Diabetes Therapy. 2020;11(3):607-619.
Alanzi T. mHealth for Diabetes Self-Management in the Kingdom of Saudi Arabia: Barriers and Solutions. Journal of Multidisciplinary Healthcare. 2018;11:535-546.
Gilstrap L, Chernew M, Nguyen C, et al. Association Between Clinical Practice Group Adherence to Quality Measures and Adverse Outcomes Among Adult Patients with Diabetes. JAMA Network Open. 2019;2(8):1-11.
Sherwani S, Khan H, Ekhzaimy A, Masood A, Sakharkar M. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomarker Insights. 2016;3:95-104.
Jeffrey B, Bagala M, Creighton A, Leavey T, Nicholls S, Wood C. Mobile Phone Applications and Their Use in the Self-Management of Type 2 Diabetes Mellitus: A Qualitative Study Among App Users and Non-App Users. Diabetology & Metabolic Syndrome. 2019;11:84.
van Smoorenburg A, Hertroijs D, Dekkers T, Elissen A, Melles M. Patients’ Perspective on Self-Management: Type 2 Diabetes in Daily Life. BMC Health Services Research. 2019;19(1):605.
Trawley S, Baptista S, Browne JL, Pouwer F, Speight J. The Use of Mobile Applications among Adults with Type 1 and Type 2 Diabetes: Results from the Second MILES - Australia (MILES-2) Study. Diabetes Technology & Therapeutics. 2017;19(12):730-738.
Agboola S, Jethwani K, Lopez L, Searl M, O’Keefe S, Kvedar J. Text to Move: A Randomized Controlled Trial of a Text-Messaging Program to Improve Physical Activity Behaviors in Patients with Type 2 Diabetes Mellitus. Journal of Medical Internet Research. 2016;18(11):307.
Potter E, Burstein F, Flynn D, et al. Physician-Authored Feedback in a Type 2 Diabetes Self-Management App: Acceptability Study. JMIR Formative Research. 2022;6(5).
International Diabetes Federation. Facts & Figures. 2023. Available at: https://idf.org/about-diabetes/diabetes-facts-figures/ [accessed on 18 September 2023].
Hou C, Carter B, Hewitt J, Francisa T, Mayor S. Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-Management of Diabetes? A Systematic Review, Meta-Analysis, and GRADE of 14 Randomized Trials. Diabetes Care. 2016;39(11):2089-2095.
Xu R, Xing M, Javaherian K, Peters R, Ross W, Bernal-Mizrachi C. Improving HbA1c with Glucose Self-Monitoring in Diabetic Patients with EpxDiabetes, a Phone Call and Text Message-Based Telemedicine Platform: A Randomized Controlled Trial. Telemedicine and e-Health. 2020;26(6):784-793.
Nepper M, McAtee J, Wheeler L, Chai W. Mobile Phone Text Message Intervention on Diabetes Self-Care Activities, Cardiovascular Disease Risk Awareness, and Food Choices Among Type 2 Diabetes Patients. Nutrients. 2019;11(6):1314.
Baptista S, Trawley S, Pouwer F, Oldenburg B, Wadley G, Speight J. What Do Adults with Type 2 Diabetes Want from the “Perfect” App? Results From the Second Diabetes MILES: Australia (MILES-2) Study. Diabetes Technology & Therapeutics. 2019;21(7):393-399.
Chavez S, Fedele D, Guo Y, Bernier A, Smith M, Warnick J. Mobile Apps for the Management of Diabetes. Diabetes Care. 2017;40(10):145-146.
Doyle-Delgado K, Chamberlain J. Use of Diabetes-Related Applications and Digital Health Tools by People with Diabetes and Their Health Care Providers. Clinical Diabetes. 2020;38(5):449-461.
Wu C, Wu Z, Yang L. Evaluation of the Clinical Outcomes of Telehealth for Managing Diabetes: A PRISMA-Compliant Meta-Analysis. Medicine. 2018;97(43):12962.
Whitehead L, Seaton P. The Effectiveness of Self-Management Mobile Phone and Tablet Apps in Long-term Condition Management: A Systematic Review. Journal of Medical Internet Research. 2016;18(5):97.
Whittemore R, Vilar-Compte M, De La Cerda S. ¡Sí, Yo Puedo Vivir Sano con Diabetes! A Self-Management Randomized Controlled Pilot Trial for Low-Income Adults with Type 2 Diabetes in Mexico City. Current Developments in Nutrition. 2020;4(5):74.
Kim E, Kwak S, Jung S, et al. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients with Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes Care. 2018;42(1):3-9.
Sun C, Sun L, Xi S, et al. Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial. JMIR mHealth and uHealth. 2019;7(1).
Di Molfetta S, Patruno P, Cormio S, et al. A Telemedicine-Based Approach with Real-Time Transmission of Blood Glucose Data Improves Metabolic Control in Insulin-Treated Diabetes: the DIAMONDS Randomized Clinical Trial. Journal of Endocrinological Investigation. 2022;45(9):1663-1671.
Groot J, Wu D, Flynn D, Robertson D, Grant G, Sun J. Efficacy of Telemedicine on Glycaemic Control in Patients with Type 2 Diabetes: A Meta-Analysis. World Journal of Diabetes. 2021;12(2):170-197.
Yin W, Liu Y, Hu H, Sun J, Liu Y, Wang Z. Telemedicine Management of Type 2 Diabetes Mellitus in Obese and Overweight Young and Middle-Aged Patients During COVID-19 Outbreak: A Single-Center, Prospective, Randomized Control Study. PloS One. 2022;17(9 September).
AlMutairi Fm, Tourkmani AM, Alrasheedy AA, et al. Cost-effectiveness of Telemedicine Care for Patients with Uncontrolled Type 2 Diabetes Mellitus During the COVID-19 Pandemic in Saudi Arabia. Therapeutic Advances in Chronic Disease. 2021;12.
Warren R, Carlisle K, Mihala G, Scuffham PA. Effects of Telemonitoring on Glycaemic Control and Healthcare Costs in Type 2 Diabetes: A Randomised Controlled Trial. Journal of Telemedicine and Telecare. 2018;24(9):586-595.
Liu Z, Wang C, Yang D, et al. High Engagement in Mobile Peer Support is Associated with Better Glycemic Control in Type 1 Diabetes: A Real-World Study. Journal of Diabetes Investigation. 2022;13(11):1914-1924.
Zhang A, Wang J, Wan X, et al. A Meta-Analysis of the Effectiveness of Telemedicine in Glycemic Management among Patients with Type 2 Diabetes in Primary Care. Internation Journal of Environmental Research and Public Health. 2022;19(7).
Krishnakumar A, Verma R, Chawla R. Evaluating Glycemic Control in Patients of South Asian Origin with Type 2 Diabetes Using a Digital Therapeutic Platform: Analysis of Real-World Data. Journal of Medical Internet Research. 2021;23(3):17908.
Tack CJ, Lancee GJ, Heeren B, et al. Glucose Control, Disease Burden, and Educational Gaps in People with Type 1 Diabetes: Exploratory Study of an Integrated Mobile Diabetes App. JMIR Diabetes 2018;3(4):17.
Ryan E, Holland J, Stroulia E, et al. Improved A1C Levels in Type 1 Diabetes with Smartphone App Use. Canadian Journal of Diabetes. 2017;41(1):33-40.
Zhang L, He X, Shen Y, et al. Effectiveness of Smartphone App-Based Interactive Management on Glycemic Control in Chinese Patients with Poorly Controlled Diabetes: Randomized Controlled Trial. Journal of Medical Internet Research. 2019;21(12).
Koot D, Goh PSC, Lim RSM, et al. A Mobile Lifestyle Management Program (GlycoLeap) for People with Type 2 Diabetes: Single-Arm Feasibility Study. JMIR mHealth and uHealth. 2019;7(5).
Alanzi T, Alanazi N, Istepanian R, Philip N. Evaluation of the Effectiveness of Mobile Diabetes Management System with Social Networking and Cognitive Behavioural Therapy (CBT) for T2D. mHealth. 2018;4(35):1-10.
DOI: https://doi.org/10.15416/pcpr.v8i2.50595
Refbacks
- There are currently no refbacks.
